NCT06475820 Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06461091 the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase N/A
NCT06452732 Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML Status RECRUITING Phase N/A
NCT06446661 Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase NA
NCT06408194 Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies Status RECRUITING Phase PHASE1
NCT06393335 Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research Status RECRUITING Phase EARLY_PHASE1
NCT06392581 Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia Patients Status RECRUITING Phase N/A
NCT06367725 Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density Status RECRUITING Phase N/A
NCT06364423 Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias Status RECRUITING Phase PHASE1/PHASE2
NCT06350994 Early Assessment of Cardiac Function After Treatment With CAR-T Cells Status RECRUITING Phase N/A
NCT06338020 Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic Leukemia Status COMPLETED Phase NA
NCT06323044 MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence Status RECRUITING Phase NA
NCT06308588 Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT06289673 Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma Status RECRUITING Phase PHASE4
NCT06287944 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome Status RECRUITING Phase PHASE1
NCT06277011 Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research Status RECRUITING Phase EARLY_PHASE1
NCT06242353 Coagulopathy in Childhood Acute Lymphoblastic Leukaemia Status NOT_YET_RECRUITING Phase N/A